Courtagen Releases Genetic Tests for Mitochondrial Disease

March 30, 2012

March 30, 2012 | Courtagen, a private genomics and proteomics company based in Woburn, Mass., has announced its first genetic test to diagnose mitochondiral disease. The company says it plans to expand test options later this year and ultimately offer a combination of multiplex proteomic and next-generation sequencing genomic assays using Illumina’s MiSeq and HiSeq platforms as well as release an 'omics app for physician clients. Mass High Tech